Crown Electrokinetics Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - USD ($)										1 Months Ended	3 Months Ended	12 Months Ended
Stockholders' Deficit (Details) - USD ($)	Apr. 27, 2021	Feb. 19, 2021	Feb. 16, 2021	Jan. 28, 2021	Jan. 26, 2021	Jan. 22, 2021	Jan. 05, 2021	Sep. 11, 2020	Jun. 06, 2020	Mar. 31, 2021	Mar. 31, 2021	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2020
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized										50,000,000	50,000,000	50,000,000	50,000,000
Preferred stock, par value (in Dollars per share)										$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
preferred stock, value (in Dollars)
common stock, par value (in Dollars per share)										$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Proceeds from public offering (in Dollars)				$ 19,300,000
Proceeds from underwriter fee and commission (in Dollars)				1,700,000
Proceeds from offering cost (in Dollars)				$ 400,000
Purchase of underwriters (in Dollars)												$ 381,800
Warrants exercise price (in Dollars per share)										$ 5.625	$ 5.625	$ 5.625
Shares issued														97,222
Warrant liability (in Dollars)								$ 600,000
Fair value warrants (in Dollars)										$ 1.1	$ 1.1	$ 1.1
Restricted common stock shares Issued										366,667
Convertible notes (in Dollars)										$ 17,100,000	17,100,000	17,100,000
Conversion feature of note exchange agreement (in Dollars)												6,600,000
Value of warrants (in Dollars)												263,328
Convertible Notes [Member]
Stockholders' Deficit (Details) [Line Items]
Fair value warrants (in Dollars)										$ 10,600,000	$ 10,600,000	$ 10,600,000
Restricted common stock shares Issued												2,830,079
Chief Executive Officer [Member]
Stockholders' Deficit (Details) [Line Items]
Restricted common stock shares Issued												1,571,428
Series A Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized							300			300	300	300	300
Preferred stock, par value (in Dollars per share)							$ 0.0001			$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
preferred stock, value (in Dollars)							$ 1,000
Annual rate, percentage							8.00%
Conversion price (in Dollars per share)							$ 1.3329
Shares issued												251
Fair value warrants (in Dollars)										$ 1,300,000	$ 1,300,000	$ 1,300,000
Restricted common stock shares Issued												251
Number of convertible shares										188,311	188,311	188,311
Value of warrants (in Dollars)
Series B Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized						1,500				1,500	1,500	1,500	1,500
Preferred stock, par value (in Dollars per share)						$ 0.0001				$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
preferred stock, value (in Dollars)						$ 1,000
Annual rate, percentage						8.00%
Conversion price (in Dollars per share)						$ 0.7149
Shares issued												1,443
Fair value warrants (in Dollars)										$ 9,400,000	$ 9,400,000	$ 9,400,000
Restricted common stock shares Issued												1,443
Number of convertible shares										2,019,038	2,019,038	2,019,038
Value of warrants (in Dollars)
Series C Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized		600,000								600,000	600,000	600,000	600,000
Preferred stock, par value (in Dollars per share)		$ 0.0001								$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
preferred stock, value (in Dollars)		$ 1.00
Annual rate, percentage		8.00%
Conversion price (in Dollars per share)		$ 0.893
Shares issued												500,756
Fair value warrants (in Dollars)										$ 2,400,000	$ 2,400,000	$ 2,400,000
Restricted common stock shares Issued												500,756
Number of convertible shares										560,757	560,757	560,757
Value of warrants (in Dollars)
Equity Option [Member]
Stockholders' Deficit (Details) [Line Items]
warrants purchased												85,000
Stock option description										During the year ended March 31, 2021, the Company issued 25,000 shares of its common stock in connection with the exercise of stock options, with an exercise price of $0.15 per share. During April 2021, the Company received proceeds of $3,750.
Common Stock [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)					$ 0.0001
Fair value warrants (in Dollars)										$ 300,000	$ 300,000	$ 300,000
Restricted common stock shares Issued	54,149											166,667
Shares issued (in Dollars)										$ 108,792
Accounts payable (in Dollars)	$ 122,000
Warrants Exercise												316,421
Value of warrants (in Dollars)
Common Stock [Member] \| Restricted Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Common stock shares issued										3	3	3
Purchase restricted stock										166,667	166,667	166,667
Fair value warrants (in Dollars)										$ 500,000	$ 500,000	$ 500,000
Restricted common stock shares Issued										800,000
Common Stock [Member] \| Financing [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)								$ 0.0001
Share price (in Dollars per share)								1.25
Warrants exercise price (in Dollars per share)								$ 1.50
Sale of aggregate shares								463,333
Purchase of warrants								231,667
Proceeds from private placement (in Dollars)								$ 1,700,000
Warrant description								The Company is not required to issue common stock upon exercise of any portion of a warrant if doing so results in the warrant holder beneficially owning more than 4.99% of the outstanding common stock after giving effect to such exercise.
Transaction fees (in Dollars)								$ 139,000
Shares issued								36,033
Common Stock [Member] \| Chief Executive Officer [Member]
Stockholders' Deficit (Details) [Line Items]
Vested restricted common stock										1,571,428	1,571,428	1,571,428
Common Stock [Member] \| Public Offering [Member]
Stockholders' Deficit (Details) [Line Items]
common stock, par value (in Dollars per share)					$ 0.0001
Sale of Stock, Number of Shares Issued in Transaction					4,772,500
Share price (in Dollars per share)					$ 4.14
Warrant [Member]
Stockholders' Deficit (Details) [Line Items]
Warrants exercise price (in Dollars per share)										$ 5.625	$ 5.625	$ 5.625
Purchase of warrants										381,800	381,800	381,800
Warrant liability (in Dollars)												$ 2,360,543	$ 16,928
Fair value warrants (in Dollars)									$ 100,000
Restricted common stock shares Issued			53,093
Shares issued (in Dollars)											$ 200,000	$ 200,000
warrants purchased									116,667			208,000
Warrants Exercise			53,093								53,093
Value of warrants (in Dollars)			$ 200,000
Warrants description										During the year ended March 31, 2021, the Company issued 166,106 shares of its common stock in connection with the exercise of 166,667 common stock warrants on a cashless basis.